SGER: Investigation of Antimicrobial Resistance Genes in the Annotation of Bacillus Anthracis Genomens

SGER：炭疽杆菌基因组注释中抗菌素耐药性基因的研究

• 批准号: 0844451
• 负责人: Linda Weigel
• 金额: --
• 依托单位: CDC/CCID/NZVED/BDFBMD/BZB
• 依托单位国家: 美国
• 项目类别: Interagency Agreement
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-08-01 至 2009-07-31
• 项目状态: 已结题
• 来源: https://www.nsf.gov/awardsearch/showAward?AWD_ID=0844451&HistoricalAwards=false
• 关键词: SGER; Investigation; Antimicrobial; Resistance; Genes

Funds are being provided to the Centers for Disease Control and Prevention via an interagency transfer for a new project on antibiotic resistance and antibiotic gene annotation in the Bacillus anthracis genome. Bacillus anthracis is an important pathogen that is sensitive to many antibiotics. Yet it, curiously, carries genetic coding for resistance to many of these same antibiotics. Through laboratory experiments, this research will determine which of the loci identified as penicillin, tetracycline, or macrolide resistance genes in strains of B. anthracis actually encode a resistance determinant; the incorrect annotations will be corrected based on the verified data. DNA sequences upstream and downstream of the resistance determinants will be analyzed to determine if mobile genetic elements are present. This research will improve the quality and usefulness of B. anthracis genome annotations. The potential for developing a resistant phenotype when the organism is exposed to antimicrobial agents will also be investigated. All corrections to genome annotations will be made available to the scientific community by submission to public databases. Data on gene identification, expression, and associated antimicrobial susceptibility phenotypes will be published in appropriate peer-reviewed journals. This project will be providing student training in bacterial genetics, bioinformatics, and molecular laboratory techniques. Validated information on antimicrobial resistance genes in biothreat agents is of particular importance to national biodefense. Any potential for resistance must be confirmed and taken into consideration when selecting an antimicrobial agent for widespread distribution and for mass treatment of the public. Any diversity detected and verified in the antimicrobial resistance genes or in the associated DNA sequences will be extremely important in identifying and tracking B. anthracis strains for microbial forensics.

正在通过机构间转移向疾病控制和预防中心提供资金，用于一个关于炭疽杆菌基因组中抗生素耐药性和抗生素基因注释的新项目。炭疽杆菌是一种对多种抗生素敏感的重要病原菌。然而，奇怪的是，它携带着对许多相同抗生素产生耐药性的遗传编码。通过实验室实验，本研究将确定哪些位点被鉴定为B菌株中的青霉素、四环素或大环内酯类耐药基因。炭疽菌实际上编码一个抗性决定子;将根据核实的数据纠正不正确的注释。将分析耐药决定簇上游和下游的DNA序列，以确定是否存在移动的遗传元件。本研究将提高B的质量和实用性。炭疽菌基因组注释。还将研究微生物暴露于抗菌剂时产生耐药表型的可能性。对基因组注释的所有更正将通过提交公共数据库向科学界提供。有关基因鉴定、表达和相关抗菌药物敏感性表型的数据将发表在适当的同行评审期刊上。该项目将为学生提供细菌遗传学、生物信息学和分子实验室技术方面的培训。生物威胁剂中抗菌素耐药性基因的验证信息对国家生物防御特别重要。在选择用于广泛分布和公众大规模治疗的抗菌剂时，必须确认和考虑任何耐药性的可能性。在抗菌素耐药基因或相关DNA序列中检测和验证的任何多样性对于识别和追踪B都将是极其重要的。炭疽菌菌株用于微生物法医学。